News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Envisia Therapeutics To Present New Glaucoma And AMD Data At Association for Research in Vision & Ophthalmology 2014


5/1/2014 2:23:35 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Envisia Therapeutics today announced that it will present data for its next generation product candidates, ENV515 for glaucoma and ENV705 for age-related macular degeneration (AMD), as well as new data for the company’s novel drug delivery systems designed for the posterior and anterior segments of the eye, at the Association for Research in Vision and Ophthalmology (ARVO) 2014 Annual Meeting.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES